Journal of clinical medicine
Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience.
Yasa Gul Mutlu, Ebrar Uzunabdullah, Duha Yahya, Hasan Basri Ergün, Süreyya Yiğit Kaya, Senem Maral, Hüseyin Saffet Beköz, Leylagül Kaynar, Ömür Gökmen Sevindik
Published: 202610.3390/jcm15020453
Abstract
Background/Objectives: Multiple myeloma (MM) patients receiving immunomodulatory drugs (IMiDs) are at increased risk of venous thromboembolism (VTE). Standard prophylaxis typically involves aspirin or low-molecular-weight heparin (LMWH), guided by ri…
Preview only. Read the full abstract at the source